Kumar-Singh Samir, Cras Patrick, Wang Rong, Kros John M, van Swieten Johan, Lübke Ursula, Ceuterick Chantal, Serneels Sally, Vennekens Krist'l, Timmermans Jean-Pierre, Van Marck Eric, Martin Jean-Jacques, van Duijn Cornelia M, Van Broeckhoven Christine
Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium.
Am J Pathol. 2002 Aug;161(2):507-20. doi: 10.1016/S0002-9440(10)64207-1.
Alzheimer's disease (AD) is characterized by deposition of beta-amyloid (Abeta) in diffuse and senile plaques, and variably in vessels. Mutations in the Abeta-encoding region of the amyloid precursor protein (APP) gene are frequently associated with very severe forms of vascular Abeta deposition, sometimes also accompanied by AD pathology. We earlier described a Flemish APP (A692G) mutation causing a form of early-onset AD with a prominent cerebral amyloid angiopathy and unusually large senile plaque cores. The pathogenic basis of Flemish AD is unknown. By image and mass spectrometric Abeta analyses, we demonstrated that in contrast to other familial AD cases with predominant brain Abeta42, Flemish AD patients predominantly deposit Abeta40. On serial histological section analysis we further showed that the neuritic senile plaques in APP692 brains were centered on vessels. Of a total of 2400 senile plaque cores studied from various brain regions from three patients, 68% enclosed a vessel, whereas the remainder were associated with vascular walls. These observations were confirmed by electron microscopy coupled with examination of serial semi-thin plastic sections, as well as three-dimensional observations by confocal microscopy. Diffuse plaques did not associate with vessels, or with neuritic or inflammatory pathology. Together with earlier in vitro data on APP692, our analyses suggest that the altered biological properties of the Flemish APP and Abeta facilitate progressive Abeta deposition in vascular walls that in addition to causing strokes, initiates formation of dense-core senile plaques in the Flemish variant of AD.
阿尔茨海默病(AD)的特征是β-淀粉样蛋白(Aβ)在弥漫性和老年斑中沉积,在血管中也有不同程度的沉积。淀粉样前体蛋白(APP)基因的Aβ编码区域发生突变,常与非常严重的血管性Aβ沉积形式相关,有时还伴有AD病理改变。我们之前描述过一种佛兰芒APP(A692G)突变,它导致一种早发性AD,伴有显著的脑淀粉样血管病和异常大的老年斑核心。佛兰芒AD的致病基础尚不清楚。通过图像分析和质谱Aβ分析,我们证明,与其他以脑内Aβ42为主的家族性AD病例不同,佛兰芒AD患者主要沉积Aβ40。通过连续组织切片分析,我们进一步表明,APP692大脑中的神经炎性老年斑以血管为中心。在对三名患者不同脑区的总共2400个老年斑核心进行研究时,68%的核心包围着一条血管,其余的则与血管壁相关。这些观察结果通过电子显微镜结合连续半薄塑料切片检查以及共聚焦显微镜的三维观察得到了证实。弥漫性斑块与血管、神经炎性或炎症病理均无关联。结合之前关于APP692的体外数据,我们的分析表明,佛兰芒APP和Aβ生物学特性的改变促进了Aβ在血管壁中的渐进性沉积,这除了导致中风外,还引发了佛兰芒AD变体中致密核心老年斑的形成。